Alpha-Synuclein: The Gateway to Parkinsonism - Innsbruck
Innsbruck Medical University, Innsbruck, Austria
February 11-13, 2015
This conference features an internationally renowned faculty of researchers, scientists and clinicians who will present on alpha-synuclein related to Parkinson’s disease and parkinsonism during this three-day event.
The first day’s sessions will highlight genetics and environment as it is linked to alpha-synuclein, advances in PD biomarkers and non-motor aspects of Parkinson’s disease.
The second day will address intracellular disruption by alpha-synuclein, extracellular alpha-synuclein, and multiple system atrophy; while the third day will discuss emerging therapies. Each session will include a roundtable discussion where participants will be able to interact with the session’s faculty members and ask pressing questions.
In addition, participants are invited to submit abstracts for a poster presentation on the second day – prize money will be awarded to the top three presentations, as judged by the Scientific Advisory Board for the conference.
At the conclusion of this activity, participants should be able to accomplish the following:
Define the role of alpha-synuclein in the pathogenesis of PD and MSA
Discuss the pros and cons of prion-like propagation in PD and related disorders
Identify clinical features in the premotor phase of PD and MSA
Critically discuss the value of biomarkers in the early diagnosis of PD and MSA
Review disease modification interventions in PD and MSA including immunization
This course is recommended for neuroscientists and movement disorder neurologists with an interest in alpha-synucleinopathies such as Parkinson`s disease and multiple system atrophy.